These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 17393784)
21. [Detection of P504S (alpha-methylacyl-CoA racemase) in prostatic adenocarcinomas]. Xiao Y; Chen J; Luo YF; Cao JL; Ling Q; Jin F Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1362-6. PubMed ID: 15387946 [TBL] [Abstract][Full Text] [Related]
22. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study. Wang W; Sun X; Epstein JI Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595 [TBL] [Abstract][Full Text] [Related]
23. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Epstein JI; Egevad L; Humphrey PA; Montironi R; Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122 [TBL] [Abstract][Full Text] [Related]
24. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Jiang Z; Li C; Fischer A; Dresser K; Woda BA Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047 [TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204 [TBL] [Abstract][Full Text] [Related]
26. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer. Zhigang Z; Wenlv S Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669 [TBL] [Abstract][Full Text] [Related]
27. [Evaluation of p63 and p504s markers for the diagnosis of prostate cancer]. Molinié V; Vieillefond A; Michiels JF; Ann Pathol; 2008 Oct; 28(5):417-23. PubMed ID: 19068396 [TBL] [Abstract][Full Text] [Related]
28. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy. Carswell BM; Woda BA; Wang X; Li C; Dresser K; Jiang Z Histopathology; 2006 May; 48(6):668-73. PubMed ID: 16681682 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations. Kunju LP; Rubin MA; Chinnaiyan AM; Shah RB Am J Clin Pathol; 2003 Nov; 120(5):737-45. PubMed ID: 14608901 [TBL] [Abstract][Full Text] [Related]
30. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody. Oliai BR; Kahane H; Epstein JI Am J Surg Pathol; 2002 Sep; 26(9):1151-60. PubMed ID: 12218571 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy. Molinié V; Hervé JM; Lugagne PM; Lebret T; Botto H BJU Int; 2006 May; 97(5):1109-15. PubMed ID: 16643500 [TBL] [Abstract][Full Text] [Related]
32. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Molinié V; Fromont G; Sibony M; Vieillefond A; Vassiliu V; Cochand-Priollet B; Hervé JM; Lebret T; Baglin AC Mod Pathol; 2004 Oct; 17(10):1180-90. PubMed ID: 15205683 [TBL] [Abstract][Full Text] [Related]
34. 34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts. Pierconti F; Rossi ED; Martini M; Sacco E; Bassi PF; Larocca LM Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):306-310. PubMed ID: 29346181 [TBL] [Abstract][Full Text] [Related]
35. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance]. Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704 [TBL] [Abstract][Full Text] [Related]
36. Prostate cancer antigen-1 as a potential novel marker for prostate cancer. Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469 [TBL] [Abstract][Full Text] [Related]
37. Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens. Trpkov K; Bartczak-McKay J; Yilmaz A Am J Clin Pathol; 2009 Aug; 132(2):211-20; quiz 307. PubMed ID: 19605815 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Weinstein MH; Signoretti S; Loda M Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011 [TBL] [Abstract][Full Text] [Related]
39. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers. Shah RB; Tadros Y; Brummell B; Zhou M Hum Pathol; 2013 May; 44(5):786-94. PubMed ID: 23158212 [TBL] [Abstract][Full Text] [Related]